A recent comprehensive meta-analysis found type 2 diabetes risk alleles at eight variants in TCF7L2 were associated with increased risk of breast, colorectal and lung cancer and glioma [15]. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.